News - Unibest Industrial Co., Ltd.

Blogs

Welcome to Unibest's Blogs section! Here, you will find valuable insights and in-depth reports covering various topics related to drugs and diseases. Our blogs aim to provide an enhanced understanding of the clinical significance and breakthroughs your clients can make. Stay updated with the latest trends, technological advancements, and industry analyses as we dive deep into the world of pharmaceuticals, giving you the knowledge and resources you need to stay ahead of the competition.

The Complement System: A Frontier in Drug Development
2024-06-12

The complement system has long been recognized as a crucial component of the innate immune system, acting as the first line of defense against invading pathogens. However, recent advancements in understanding this intricate network have unveiled its multifaceted roles in various physiological proces Read More
Avacopan - Orphan Drug with a Growing Market
2024-06-07

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA-associated vasculitis) is a rare but serious autoimmune disease affecting small blood vessels. With a global prevalence estimated between 30-218 cases per million, it leads to inflammation of blood vessels and potential organ damage. C Read More
Tirzepatide Approved by NMPA for Type II Diabetes
2024-05-21

On May 21st, the Chinese National Medical Products Administration (NMPA) approved Tirzepatide (brand name Mounjaro), a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed by Lilly, for the improvement of glycemic control in adults wi Read More
Opportunities for API Manufacturers in the Expanding Ruxolitinib Market
2024-05-15

Ruxolitinib, a groundbreaking product of Incyte Corp, has demonstrated an impressive evolution in the pharmaceutical market. Its strategic journey from a niche treatment for rare diseases to a versatile solution for more common dermatological conditions not only emphasizes the strategic significance Read More
Drug Briefing: Avacopan
2024-05-10

Query Drug：AvacopanQuery Time：2024-06-04 09:21:05*** Disclaimer *** The information provided here is sourced from resources such as Drugs.com, the Orange Book, etc., and is auto-generated by the Unibest Digital Center. The content is intended exclusively for pharmaceutical professionals. Unibest doe Read More
Drug Briefing: Ruxolitinib
2024-04-25

Query Drug：RuxolitinibQuery Time：2024-04-25 09:12:38*** Disclaimer *** The information provided here is sourced from resources such as Drugs.com, the Orange Book, etc., and is auto-generated by the Unibest Digital Center. The content is intended exclusively for pharmaceutical professionals. Unibest Read More
Case Study of Flow Chemistry in the Synthesis of Pharmaceutical Ingredient Belzutifan
2024-04-23

IntroductionIn a previous article, we discussed when to consider using flow chemistry over conventional batch processes for chemical synthesis. One compelling example highlighting the advantages of flow chemistry comes from the manufacturing route development for belzutifan, a recently approved drug Read More
Scaling the Everest of Pharma Synthesis: A Deep Dive into Eribulin's Journey
2024-04-19

As one steps into the realm of pharmaceutical discovery, the name Eribulin, also known as Halaven, rings a powerful note. First approved in 2010 by Eisai, this non-peptide drug, intricate in its synthesis and impressive in the magnitude of its medical impact, has been nothing short of groundbreaking Read More
Drug Briefing: Belzutifan
2024-04-11

Query Drug：BelzutifanQuery Time：2024-04-11 13:18:28 Read More